...
首页> 外文期刊>Journal of clinical laboratory analysis. >The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): Interference of C‐reactive protein
【24h】

The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): Interference of C‐reactive protein

机译:活化的部分凝血活酶时间的假延长分析(活化剂:二氧化硅):C反应蛋白的干扰

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background To investigate the effect of C‐reactive protein on the activated partial thromboplastin time (APTT) (different activators) in different detecting systems. Methods The C‐reactive protein and coagulation test of 112 patients with the infectious disease were determined by automation protein analyzer IMMAG 800 and automation coagulation analyzer STA‐R Evolution, respectively. The pooled plasma APTT with different concentrations of C‐reactive protein was measured by different detecting system: STA‐R Evolution (activator: silica, kaolin), Sysmex CS‐2000i (activator: ellagic acid), and ACL TOP 700 (activator: colloidal silica). In addition, the self‐made platelet lysate (phospholipid) was added to correct the APTT prolonged by C‐reactive protein (150?mg/L) on STA‐R Evolution (activator: silica) system. Results The good correlation between C‐reactive protein and APTT was found on the STA‐R Evolution (activator: silica) system. The APTT on the STA‐R Evolution (activator: silica) system was prolonged by 24.6?second, along with increasing C‐reactive protein concentration. And the APTT of plasma containing 150?mg/L C‐reactive protein was shortened by 3.4‐6.9?second when the plasma was mixed with self‐made platelet lysate. However, the APTT was prolonged unobviously on other detecting systems including STA‐R Evolution (activator: kaolin), Sysmex CS‐2000i, and ACL TOP 700. Conclusion C‐reactive protein interferes with the detection of APTT, especially in STA‐R Evolution (activator: silica) system. The increasing in C‐reactive protein results in a false prolongation of the APTT (activator: silica), and it is most likely that C‐reactive protein interferes the coagulable factor binding of phospholipid.
机译:背景为了研究C反应蛋白对不同检测系统中活化的部分凝血活酶时间(APTT)(不同的活化剂)的影响。方法分别通过自动化蛋白质分析仪IMMAG 800和自动化凝血分析仪STA‐R Evolution确定112例传染病患者的C反应蛋白和凝血试验。通过不同的检测系统测量了具有不同C反应蛋白浓度的合并血浆APTT:STA‐R Evolution(活化剂:二氧化硅,高岭土),Sysmex CS‐2000i(活化剂:鞣花酸)和ACL TOP 700(活化剂:胶体)二氧化硅)。此外,添加了自制的血小板裂解物(磷脂)以纠正在STA-R Evolution(活化剂:硅胶)系统上被C反应蛋白(150?mg / L)延长的APTT。结果在STA-R Evolution(活化剂:二氧化硅)系统上发现了C反应蛋白与APTT之间的良好相关性。随着C反应蛋白浓度的增加,STA‐R Evolution(活化剂:二氧化硅)系统上的APTT延长了24.6?s。当血浆与自制的血小板裂解液混合时,含150?mg / L C反应蛋白的血浆的APTT缩短了3.4-6.9?s。但是,APTT在其他检测系统(包括STA-R Evolution(激活剂:高岭土),Sysmex CS-2000i和ACL TOP 700)上的延长明显。结论C反应蛋白会干扰APTT的检测,尤其是在STA-R Evolution中(活化剂:二氧化硅)体系。 C反应蛋白的增加会导致APTT的假延长(活化剂:二氧化硅),并且C反应蛋白最有可能干扰磷脂的凝血因子结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号